Bioavailability Assessment

Bioavailability Assessment is a pharmacokinetic evaluation that quantifies, typically by noncompartmental analysis of concentration–time data, the rate and extent to which an active drug ingredient or moiety is absorbed from a dosage form and becomes available at the site of action or in the systemic circulation.

1.6K

Publications

90K

Citations

6.5K

Authors

1.6K

Institutions

Publications per year

2017–2026

195

Authors

6.5K

  1. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    21 publications · 9K citations

    16

    h-index

  2. JD
    Jennifer Dressman

    Goethe University Frankfurt, Germany

    15 publications · 896 citations

    13

    h-index

  3. KK
    Kamal K. Midha

    University of Saskatchewan, Canada

    10 publications · 2.1K citations

    9

    h-index

  4. NK
    Nahoko Kaniwa

    National Institute of Health Sciences, Japan

    9 publications · 180 citations

    9

    h-index

  5. PG
    Peter G. Welling

    University of Wisconsin–Madison, United States

    9 publications · 384 citations

    9

    h-index

1–5 of 6.5K

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 57 publications · 4.1K citations

    36

    h-index

  2. PubMed

    Repository · 141 publications · 5K citations

    34

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 54 publications · 4.1K citations

    32

    h-index

  4. Journal of Pharmaceutical Sciences

    78 publications · 4K citations

    31

    h-index

  5. The Journal of Clinical Pharmacology

    50 publications · 3K citations

    30

    h-index

1–5